On April 23, Zhejiang Medicine (600216) released its 2018 annual report. 2018, the company achieved operating income of 6.859 billion yuan, an increase of 20.49% year-on-year. During the reporting period, the company's Life Nutrition (note: use of dietary supplements in the field) to achieve sales of 2.67 billion yuan, accounting for 38.93% of the company's operating income, an increase of 9.41% year earlier, life nutrition products gross margin of 39.23%, more than the previous year increased by 10.87%. In addition, the company obtained 5 health food filling number.
In January 2018, the company's subsidiary Zhejiang Innovation Biology Co., Ltd. ("Innovative Creature") received a food production license issued by Zhejiang Provincial Drug Administration, the category of health food. The workshop, which obtained the certification of production license, is the oral solid preparation workshop of health food and the soft capsule workshop of health food, and the Workshop department is certified for the first time after new construction. By the end of the reporting period, the company's health food production had been fully transferred to innovative organisms for production.
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year